ACP5

acid phosphatase 5, tartrate resistant, the group of Acid phosphatases

Basic information

Region (hg38): 19:11574653-11579993

Links

ENSG00000102575NCBI:54OMIM:171640HGNC:124Uniprot:P13686AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Spondyloenchondrodysplasia with immune dysregulation (Definitive), mode of inheritance: AR
  • Spondyloenchondrodysplasia with immune dysregulation (Strong), mode of inheritance: AR
  • Spondyloenchondrodysplasia with immune dysregulation (Strong), mode of inheritance: AR
  • Spondyloenchondrodysplasia with immune dysregulation (Supportive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Spondyloenchondrodysplasia with immune dysregulationARAllergy/Immunology/InfectiousIndividuals may have immune deficiency, and a variety of infections have been reported, including pneunomia, upper respiratory infections, and severe varicella infections, and thus antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficial; Individuals may also have a variety of autoimmune manifestations, including hypothyroidism, and treatment may be beneficialAllergy/Immunology/Infectious; Endocrine; Musculoskeletal; Neurologic12786759; 17497723; 17163538; 18924170; 21217755; 21217752; 26854080; 26951490
Clinically recognizable non-immune features may not be recognized early; The condition can affect multiple organ systems for which early knowledge of disease could be beneficial, including infectious and autoimmune sequelae

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ACP5 gene.

  • Spondyloenchondrodysplasia_with_immune_dysregulation (293 variants)
  • Inborn_genetic_diseases (40 variants)
  • not_provided (26 variants)
  • ACP5-related_disorder (7 variants)
  • not_specified (5 variants)
  • See_cases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACP5 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001611.5. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
78
clinvar
5
clinvar
83
missense
6
clinvar
5
clinvar
142
clinvar
9
clinvar
2
clinvar
164
nonsense
7
clinvar
1
clinvar
2
clinvar
10
start loss
1
1
frameshift
16
clinvar
3
clinvar
19
splice donor/acceptor (+/-2bp)
1
clinvar
1
Total 30 9 145 87 7

Highest pathogenic variant AF is 0.0000427454

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ACP5protein_codingprotein_codingENST00000592828 44349
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.07870.9121257330151257480.0000596
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.4001811970.9200.00001282096
Missense in Polyphen5078.8180.63437894
Synonymous0.5608086.60.9240.00000580687
Loss of Function2.25412.60.3176.33e-7121

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001740.000174
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00006170.0000615
Middle Eastern0.000.00
South Asian0.00003270.0000327
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Involved in osteopontin/bone sialoprotein dephosphorylation. Its expression seems to increase in certain pathological states such as Gaucher and Hodgkin diseases, the hairy cell, the B-cell, and the T-cell leukemias.;
Disease
DISEASE: Spondyloenchondrodysplasia with immune dysregulation (SPENCDI) [MIM:607944]: A disease characterized by vertebral and metaphyseal dysplasia, spasticity with cerebral calcifications, and strong predisposition to autoimmune diseases. The skeletal dysplasia is characterized by radiolucent and irregular spondylar and metaphyseal lesions that represent islands of chondroid tissue within bone. {ECO:0000269|PubMed:21217752, ECO:0000269|PubMed:21217755}. Note=The disease is caused by mutations affecting the gene represented in this entry. ACP5 inactivating mutations result in a functional excess of phosphorylated osteopontin causing deregulation of osteopontin signaling and consequential autoimmune disease.;
Pathway
Lysosome - Homo sapiens (human);Riboflavin metabolism - Homo sapiens (human);Rheumatoid arthritis - Homo sapiens (human);Osteoclast differentiation - Homo sapiens (human);Osteoclast Signaling;RANKL-RANK (Receptor activator of NFKB (ligand)) Signaling Pathway;Metabolism;Vitamin B2 (riboflavin) metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors (Consensus)

Recessive Scores

pRec
0.254

Intolerance Scores

loftool
0.138
rvis_EVS
0.35
rvis_percentile_EVS
74.58

Haploinsufficiency Scores

pHI
0.161
hipred
N
hipred_score
0.429
ghis
0.394

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.995

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Acp5
Phenotype
hematopoietic system phenotype; immune system phenotype; skeleton phenotype; limbs/digits/tail phenotype;

Gene ontology

Biological process
ossification;riboflavin metabolic process;dephosphorylation;response to lipopolysaccharide;negative regulation of interleukin-1 beta production;negative regulation of interleukin-12 production;negative regulation of tumor necrosis factor production;negative regulation of superoxide anion generation;response to cytokine;negative regulation of nitric oxide biosynthetic process;bone resorption;negative regulation of inflammatory response;defense response to Gram-positive bacterium;bone morphogenesis
Cellular component
lysosome;cytosol;integral component of membrane
Molecular function
acid phosphatase activity;ferrous iron binding;ferric iron binding